These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
90 related articles for article (PubMed ID: 26261680)
1. Comments on Bu et al. "P16(INK₄a) overexpression and survival in osteosarcoma patients: a meta analysis". Yan MM; Ni JD Int J Clin Exp Pathol; 2015; 8(6):7617-8. PubMed ID: 26261680 [TBL] [Abstract][Full Text] [Related]
2. Comments on the article of Bu, et al entitled "P16INK4a overexpression and survival in osteosarcoma patients: a meta analysis". Liu F; Zhou D; Zhang Q; Wang B Int J Clin Exp Pathol; 2015; 8(3):3384-5. PubMed ID: 26045875 [No Abstract] [Full Text] [Related]
3. P16INK4a overexpression and survival in osteosarcoma patients: a meta analysis. Bu J; Li H; Liu LH; Ouyang YR; Guo HB; Li XY; Xiao T Int J Clin Exp Pathol; 2014; 7(9):6091-6. PubMed ID: 25337256 [TBL] [Abstract][Full Text] [Related]
4. p16 expression as a prognostic and predictive marker in high-grade localized osteosarcoma of the extremities: an analysis of 357 cases. Righi A; Gambarotti M; Sbaraglia M; Sisto A; Ferrari S; Dei Tos AP; Picci P Hum Pathol; 2016 Dec; 58():15-23. PubMed ID: 27544803 [TBL] [Abstract][Full Text] [Related]
5. p16 expression predicts neoadjuvant tumor necrosis in osteosarcomas: reappraisal with a larger series using whole sections. Kosemehmetoglu K; Ardic F; Karslioglu Y; Kandemir O; Ozcan A Hum Pathol; 2016 Apr; 50():170-5. PubMed ID: 26997452 [TBL] [Abstract][Full Text] [Related]
6. Up-regulation of expression and lack of 5' CpG island hypermethylation of p16 INK4a in HPV-positive cervical carcinomas. Ivanova TA; Golovina DA; Zavalishina LE; Volgareva GM; Katargin AN; Andreeva YY; Frank GA; Kisseljov FL; Kisseljova NP BMC Cancer; 2007 Mar; 7():47. PubMed ID: 17359536 [TBL] [Abstract][Full Text] [Related]
7. p16(INK4a) expression in retinoblastoma: a marker of differentiation grade. Liu Y; Zhong X; Wan S; Zhang W; Lin J; Zhang P; Li Y Diagn Pathol; 2014 Dec; 9():180. PubMed ID: 25499675 [TBL] [Abstract][Full Text] [Related]
8. Comments on Li H et al. "A systematic review of matrix metalloproteinase 9 as a biomarker of survival in patients with osteosarcoma". Zhang Q; Li J; Liu F; Li Z Tumour Biol; 2015 Jan; 36(1):5-6. PubMed ID: 25416443 [TBL] [Abstract][Full Text] [Related]
9. Increased expression of senescence markers p14(ARF) and p16(INK4a) in breast cancer is associated with an increased risk of disease recurrence and poor survival outcome. Pare R; Shin JS; Lee CS Histopathology; 2016 Sep; 69(3):479-91. PubMed ID: 26843058 [TBL] [Abstract][Full Text] [Related]
11. Overexpression of p16 INK4a as an indicator for human papillomavirus oncogenic activity in cervical squamous neoplasia. Ishikawa M; Fujii T; Saito M; Nindl I; Ono A; Kubushiro K; Tsukazaki K; Mukai M; Nozawa S Int J Gynecol Cancer; 2006; 16(1):347-53. PubMed ID: 16445657 [TBL] [Abstract][Full Text] [Related]
12. Immunostaining for polycomb group protein EZH2 and senescent marker p16INK4a may be useful to differentiate cholangiolocellular carcinoma from ductular reaction and bile duct adenoma. Sasaki M; Matsubara T; Kakuda Y; Sato Y; Nakanuma Y Am J Surg Pathol; 2014 Mar; 38(3):364-9. PubMed ID: 24487593 [TBL] [Abstract][Full Text] [Related]
13. P16 protein expression as a useful predictive biomarker for neoadjuvant chemotherapy response in patients with high-grade osteosarcoma: A systematic meta-analysis under guideline of PRISMA. Tang Y; Yang C; Guo Z; Fu Y; Yu X; Liu B; Zhou H; Wang J; Li W; Pang Q Medicine (Baltimore); 2017 May; 96(19):e6714. PubMed ID: 28489748 [TBL] [Abstract][Full Text] [Related]
14. p16INK4A in oral squamous cell carcinomas--a correlation with biological behaviors: immunohistochemical and FISH analysis. Suzuki H; Sugimura H; Hashimoto K J Oral Maxillofac Surg; 2006 Nov; 64(11):1617-23. PubMed ID: 17052587 [TBL] [Abstract][Full Text] [Related]
15. Prognostic significance of p16 Lin G; Lou Y Indian J Cancer; 2017; 54(3):580-583. PubMed ID: 29798963 [TBL] [Abstract][Full Text] [Related]
16. p16INK4a and p14ARF methylation as a potential biomarker for human bladder cancer. Kawamoto K; Enokida H; Gotanda T; Kubo H; Nishiyama K; Kawahara M; Nakagawa M Biochem Biophys Res Commun; 2006 Jan; 339(3):790-6. PubMed ID: 16316628 [TBL] [Abstract][Full Text] [Related]
17. Significance of cell cycle regulatory proteins as malignant and prognostic biomarkers in ovarian epithelial tumors. Lee YH; Heo JH; Kim TH; Kang H; Kim G; Kim J; Cho SH; An HJ Int J Gynecol Pathol; 2011 May; 30(3):205-17. PubMed ID: 21464733 [TBL] [Abstract][Full Text] [Related]
18. The overexpression of p16 is not a surrogate marker for high-risk human papilloma virus genotypes and predicts clinical outcomes for vulvar cancer. Sznurkowski JJ; Żawrocki A; Biernat W BMC Cancer; 2016 Jul; 16():465. PubMed ID: 27411473 [TBL] [Abstract][Full Text] [Related]
20. Molecular analysis of the INK4A/INK4A-ARF gene locus in conventional (central) chondrosarcomas and enchondromas: indication of an important gene for tumour progression. van Beerendonk HM; Rozeman LB; Taminiau AH; Sciot R; Bovée JV; Cleton-Jansen AM; Hogendoorn PC J Pathol; 2004 Mar; 202(3):359-66. PubMed ID: 14991902 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]